𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low-dose tumor necrosis factor-α augments antitumor activity of stealth liposomal doxorubicin (DOXIL®) in soft tissue sarcoma-bearing rats

✍ Scribed by Timo L.M. Ten Hagen; Alexander H. Van Der Veen; Peet T.G.A. Nooijen; Sandra T. Van Tiel; Ann L.B. Seynhaeve; Alexander M.M. Eggermont

Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
354 KB
Volume
87
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biodistribution and tumor localization o
Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-α in soft tissue sarcoma bearing rats
✍ Alexander H. van der Veen; Alexander M. M. Eggermont; Ann L. B. Seynhaeve; Sandr 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 98 KB

The blood residence half-life and organ distribution of recombinant human tumor necrosis factor-alpha (TNF-alpha) encapsulated in sterically stabilized liposomes, were investigated in rats bearing a soft tissue sarcoma in the hind leg. We studied the decay in blood concentration of "empty" liposomes

Pegylated liposomal tumor necrosis facto
Pegylated liposomal tumor necrosis factor-α results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil®) in soft tissue sarcoma-bearing rats
✍ Timo L.M. ten Hagen; Ann L.B. Seynhaeve; Sandra T. van Tiel; Dirk J. Ruiter; Ale 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB

## Abstract Previously we reported that encapsulation of tumor necrosis factor‐α (TNF) in pegylated (STEALTH®) liposomes (TNF‐PEGL) dramatically improved circulation times of the protein and augmented accumulation in tumor tissue. We and others have demonstrated enhanced antitumor activity of doxor